Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma

Bovie Medical has announced a sales channel partnership agreement with Hologic, effective immediately.
 
Hologic will add Bovie’s J-Plasma product line to its portfolio of healthcare solutions in gynecological and gynecological/oncological surgery in three U.S. regions.
 
The initial six-month agreement provides certain members of Hologic’s direct GYN Surgical sales force with access to J-Plasma and includes the option to extend the agreement into a worldwide distribution pact that would involve Hologic’s entire surgical sales force.

J-Plasma uses a helium ionization process to produce a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents through the patient during surgery.

Watch the video below to learn more about J-Plasma:

 

“We are proud to partner with a company of Hologic’s caliber. This agreement is an important milestone in our strategy to scale J-Plasma through select sales channel partnerships across multiple specialties that represent large addressable market opportunities,” Bovie Medical CEO Robert L. Gershon said.
 
Thomas P. O’Neill, Hologic Division President, GYN Surgical Solutions added, “J-Plasma’s reputation for precision and safety makes it an ideal product for surgical procedures involving delicate surrounding tissue and structures. This agreement aligns with our strategy of providing our customers with cutting-edge technology that makes a real difference in patients’ lives.”
 
Bovie Medical Corporation manufactures medical devices and supplies, and developed J-Plasma, a patented new plasma-based surgical product for cutting and coagulation. Bovie Medical also makes a range of electrosurgical products and technologies, marketed through both private labels and the company’s own brands (Bovie, Aaron, IDS and ICON) to distributors worldwide. The Purchase, N.Y.-based company also leverages its expertise through original equipment manufacturing agreements with other medical device manufacturers.